Table 3. Comparison of key AL implementation indicators between 2006 and 2007.
| 2006 | 2007 | |
|---|---|---|
| Health facility characteristics | N=193 | N=211 |
| n (%) | n (%) | |
| Availability of antimalarial drugs on the day of the survey | ||
| Any tablet packs of artemether-lumefantrine | 169 (87.6) | 201 (95.3) |
| All tablet packs of artemether-lumefantrine | 112 (58.0) | 129 (61.1) |
| Amodiaquine (any formulation) | 193 (100) | 206 (97.6) |
| Sulfadoxine-pyrimethamine tablets | 183 (94.8) | 204 (96.7) |
| Quinine tablets | 154 (79.8) | 194 (91.9) |
| Stock-out of antimalarial drugs in past 6 months* | ||
| Any tablet packs of artemether-lumefantrine | NA | 117 (66.5) |
| All tablet packs of artemether-lumefantrine | NA | 27 (15.3) |
| Amodiaquine (both formulation) | 10 (5.2) | 4 (2.3) |
| Sulfadoxine-pyrimethamine tablets | 41 (21.2) | 9 (5.1) |
| Quinine tablets | 71 (36.8) | 26 (14.8) |
| AL case-management wall charts (all three charts) | 1 (0.5) | 40 (19.0) |
| Health worker characteristics | N=227 ** | N=654 |
| n (%) | n (%) | |
| In-service training including use of artemether-lumefantrine | 105 (46.3) | 306 (46.8) |
| Access to national malaria guidelines | 126 (55.5) | 385 (59.0) |
| Supervision including use of artemether-lumefantrine | 17 (7.5) | 127 (19.4) |
*
Stock-out in past 6 months are defined as absence of drug from the stock of at least 7 consecutive days
**
During 2006 surveys only health workers providing consultations on the day of the survey were interviewed